Nanjing Pharma

111 Inc. is a healthcare company

BRIEF: Baiyunshan invests $105 million for 11% of NanJing Pharma

Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.  (0874.HK; 600332.SH) said on Sunday it paid 749 million yuan ($105 million) via its Guangzhou GP Fund II subsidiary for 11.04% of NanJing Pharmaceutical…
0874.HK 600332.SHG 600713.SHG

Recent Articles

RELATED ARTICLES

  1. Baiyunshan supports stock price with high dividend yield despite plain business performance
    Baiyunshan serves up high dividend in lieu of vanilla results
    0874.HK 600332.SHG
  2. BRIEF: Green Economy invests $1.48 million in Bayed Health Group IPO
    1315.HK 2609.HK
  3. BRIEF: Yunfeng invests $44 million for 10,000 ether tokens
    0376.HK
  4. WuXi group wrestles with uncertainty over pharma tariffs
    2268.HK
  5. CSPC Pharma teases big bucks deals after earnings miss
    1093.HK
  6. BRIEF: Innogen launches $87 million Hong Kong IPO
  7. Will Trump’s drug order put the brakes on China’s overseas pharma drive?
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva